Deirdre P Connelly is of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 5,225 shares of SRPT, which is worth approximately $114,793. The most recent transaction as insider was on Mar 10, 2025, when has been sold 2,383 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.23K
0% 3M change
n/a 12M change
Total Value Held $114,793

Deirdre P Connelly Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 10 2025
BUY
Grant, award, or other acquisition
-
2,383 Added 31.32%
5,225 Common Stock
Sep 12 2024
BUY
Grant, award, or other acquisition
-
2,842 Added 50.0%
2,842 Common Stock

Also insider at

LNC
LINCOLN NATIONAL CORP Financial Services
M
Macy's, Inc. Consumer Cyclical
DPC

Deirdre P Connelly

Radnor, PA

Track Institutional and Insider Activities on SRPT

Follow Sarepta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRPT shares.

Notify only if

Insider Trading

Get notified when an Sarepta Therapeutics, Inc. insider buys or sells SRPT shares.

Notify only if

News

Receive news related to Sarepta Therapeutics, Inc.

Track Activities on SRPT